Stock-Based Compensation (Tables)

12 Months Ended

Dec. 31, 2022

Share Based Compensation Arrangement By Share Based Payment Award [Line Items]

Summary of Outstanding Base Options Consisted

The Company’s outstanding Base Options consisted of the following (shares in thousands):

	Shares			Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Term (in years)		Aggregate Intrinsic Value (in thousands)
Stock options outstanding as of January 1, 2022		17,201		$	4.26
Granted		995			22.80
Exercised		(6,776	)		1.70
Forfeited		(782	)		10.62
Stock options outstanding as of December 31, 2022		10,638		$	7.15		6.6	$	109,236
Expected to vest as of December 31, 2022		4,293		$	12.04		7.9	$	29,284
Exercisable as of December 31, 2022		6,345		$	3.85		5.9	$	79,952

The Company’s outstanding Upside Options consisted of the following (shares in thousands):

	Shares			Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Term (in years)		Aggregate Intrinsic Value (in thousands)
Stock options outstanding as of January 1, 2022		14,428		$	6.21
Exercised		(5,147	)		4.35
Forfeited		(114	)		14.80
Stock options outstanding as of December 31, 2022		9,167		$	7.16		5.9	$	85,160
Expected to vest as of December 31, 2022		2,335		$	11.38		7.5	$	13,072
Exercisable as of December 31, 2022		6,832		$	5.71		5.4	$	72,088

The following table summarizes employee restricted stock award activity, including performance stock units, for the year ended December 31, 2022 (units in thousands):

	Restricted Stock Units			Weighted-Average Grant-Date Fair Value
Unvested as of January 1, 2022		1,125		$	18.41
Granted		1,320			21.89
Vested		(404	)		9.77
Forfeited		(219	)		22.49
Unvested as of December 31, 2022		1,822			22.35

Base Options

Share Based Compensation Arrangement By Share Based Payment Award [Line Items]

Summary of Black-Scholes Option Pricing Model

The assumptions used for the Black-Scholes option pricing model to determine the fair value of Base Options granted are as follows:

	December 31,
	2022		2021		2020
Risk-free interest rate	1.94% -4.18%		0.75% - 1.58%		0.43% - 1.68%
Expected dividends	$	—	$	—	$	—
Expected volatility	48.66% -64.29%		58.95% - 63.33%		59.39% - 63.47%
Expected term (in years)	6.25		6.25		6.25

Non Employee Awards

Share Based Compensation Arrangement By Share Based Payment Award [Line Items]

Summary of Outstanding Base Options Consisted

summarizes Physician Partners Equity Awards activity, including performance stock units, for the year ended December 31, 2022 (units in thousands):

	Restricted Stock Units			Weighted-Average Grant-Date Fair Value
Unvested as of January 1, 2022		292		$	25.95
Granted		5,206			21.93
Vested		(38	)		25.95
Unvested as of December 31, 2022		5,460			22.12

For